ISRG Intuitive Surgical

Q3 2025 10-Q

Filed: Oct 22, 2025Period ending Sep 30, 2025

Health Care

Orthopedic, Prosthetic & Surgical Appliances & SuppliesSEC EDGAR

Intuitive Surgical (ISRG) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 22, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Management Discussion & Analysis

• Revenue $2.51B Q3 2025, up 23% YoY from $2.04B Q3 2024; 9M revenue $7.20B up 21% from $5.94B YoY
• Gross margin 66.4% Q3 2025 vs 67.4% Q3 2024; product margin 66.8% vs 67.5%; service margin 63.8% vs 66.9% (Q3 YoY)

+3 more insights

Risk Factors

• No new or changed risk factors this quarter compared to 2024 10-K
• Carried-forward regulatory risk: compliance with evolving medical device regulations globally

+2 more insights

Quarterly Financial Summary
XBRL

Revenue

$2.5B

▲ +22.9% YoY▲ +2.7% QoQ

Net Income

$704M

▲ +24.7% YoY▲ +7.0% QoQ

Gross Margin

66.4%

▼ -105bp YoY▲ +5bp QoQ

Operating Margin

30.3%

▲ +200bp YoY▼ -14bp QoQ

Net Margin

28.1%

▲ +39bp YoY▲ +114bp QoQ

ROE

4.2%

Total Assets

$19.4B

EPS (Diluted)

$1.95

▲ +25.0% YoY▲ +8.3% QoQ

Operating Cash Flow

$841M

▲ +19.0% YoY▲ +17.6% QoQ

Source: XBRL data from Intuitive Surgical Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Intuitive Surgical Quarterly Reports

Q2 2025 10-Q

Q1 2025 10-Q

Get deeper insights on Intuitive Surgical

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.